Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Baby Observational and Nutritional Study
The Baby Observational and Nutritional Study has completed, focusing on nutrition and growth in infants with cystic fibrosis and related pan…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Probiotics in Cystic Fibrosis [Phase 3]
A Phase 3 clinical trial evaluating probiotics for cystic fibrosis has completed, signaling a potential milestone in this area.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Hypertonic Saline and Mucociliary Clearance in Children [Phase 2]
Phase 2 trial in children with cystic fibrosis evaluated hypertonic saline and its effect on mucociliary clearance. Results have been posted…
-
FDA approval · 2015-09-11FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for TOBI Podhaler (tobramycin) by Viatris Specialty LLC to update the product labeling.
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: Comparison of Amikacin Lung Delivery With Two Nebulizers [NA]
This document provides an update on a clinical trial comparing two nebulizers for delivering inhaled amikacin, including healthy volunteers …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Investigating the Incretin Effect in Cystic Fibrosis
A clinical trial examining the incretin effect in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation [Phase 3]
Phase 3 trial results for lumacaftor in combination with ivacaftor in cystic fibrosis patients aged 12 and older with F508del homozygous CFT…
-
FDA approval · 2015-09-01FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated. This action updates t…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation [Phase 3]
Phase 3 study of lumacaftor in combination with ivacaftor in cystic fibrosis patients aged 12 and older who are homozygous for the F508del C…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation [Phase 2]
Phase 2 study of VX-809 (lumacaftor) in cystic fibrosis patients with the ∆F508 mutation completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session [NA]
A completed clinical trial investigated the timing of nebulization relative to a physiotherapy session in people with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa [Phase 4]
Phase 4 trial evaluating the effect of azithromycin on lung function in children aged 6-18 with cystic fibrosis not infected with Pseudomona…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis [NA]
Sponsor Texas A&M University completed a clinical trial evaluating a leucine-enriched essential amino acid mix to optimize protein anabolism…
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Effects of an Exercise Program Among CF Patients With Dysglycemia [NA]
Clinical trial update indicating a completed study on the effects of an exercise program among cystic fibrosis patients with dysglycemia.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults
The update describes a study of multiple breath nitrogen washout in healthy adults and adults with cystic fibrosis. The trial status is COMP…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Children
This completed clinical trial studied multiple breath nitrogen washout in healthy children and in children with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) [NA]
This completed clinical trial studied zinc homeostasis and kinetics in children with cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis [Phase 2]
A Phase 2 trial update reports completion of a study evaluating oral docosahexaenoic acid (DHA) supplementation in cystic fibrosis.
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Prevention of CF Exacerbation in Childhood: PREVEC Study
The PREVEC clinical trial investigating prevention of cystic fibrosis exacerbations in children has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis [NA]
A completed University of Michigan trial evaluating novel interventions to improve adherence in children with cystic fibrosis; results were …
-
CLINICAL_TRIALS withdrawal · 2015-07-09Clinical Trial Update: A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF) [Phase 1]
Gilead Sciences has withdrawn its Phase 1 trial of GS-9411 in cystic fibrosis patients, which was evaluating safety, tolerability, and pharm…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Rollover Study of VX-770 in Cystic Fibrosis Subjects [Phase 3]
Phase 3 rollover study of VX-770 (ivacaftor) in cystic fibrosis completed; results posted in 2015.
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
This completed clinical trial compares bone microarchitecture at the radius in children with cystic fibrosis to healthy controls to explore …
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis [NA]
A clinical trial update on antibiotic nephrotoxicity in adult patients with cystic fibrosis (NCT02489955); the study status is currently unk…
-
FDA approval · 2015-07-02FDA Approved: ORKAMBI — Original Application (Vertex Pharmaceuticals Incorporated)
FDA approval of ORKAMBI (lumacaftor and ivacaftor) under an original application by Vertex Pharmaceuticals for cystic fibrosis.